Judith James, MD, PhD Fulfills Childhood Dream to be a Doctor with Outstanding Career in Lupus Treatment and Research
March 14, 2022
Dr. Judith James has wanted to be a doctor since she was four years old. But it...
News
Saluting Women Shaping LRA’s Strategic Scientific Direction
March 8, 2022
In honor of Women’s History Month, the LRA is saluting the three exceptional women who serve on...
Lupus Nephritis: A Major Focus at the Lupus Research Alliance
Updated March, 2022
Developing safe and effective treatments for lupus nephritis has been an urgent and long-standing goal in the...
Catch Up on LRA News with Lupus Research Update Vol. 1, 2022
February 17, 2022
It’s with great pride that I share a sampling of the many extraordinary accomplishments of last year...
Lupus Research Alliance Congratulates Dr. Robert Califf on FDA Commissioner Appointment
February 17, 2022
The Lupus Research Alliance applauds the appointment of Dr. Robert Califf as the Commissioner of the U.S....
Encouraging Results with Obinutuzumab for Lupus Nephritis
February 13, 2022
The LRA is pleased to share a recently published paper reporting that the drug, obinutuzumab, showed positive...
LRA-Funded Research Aims at Preventing Heart Disease in Kids With Lupus
February 14, 2022
Being a kid isn't always easy, but growing up with lupus makes it a much harder challenge....
LRA-Funded Research Found a Connection Between the Epstein-Barr Virus Infection and MS as an Autoimmune Disease
February 4, 2022
A potential new cause of the autoimmune disease multiple sclerosis (MS) was discovered by researchers partly funded...
Baricitinib Development as a Lupus Treatment Discontinued
January 28, 2022
The Lupus Research Alliance is disappointed that the Phase 3 development program of OLUMIANT® (baricitinib) as a...
LRA-Funded Research Uncovers a Novel Pathway for Lupus Nephritis
January 28, 2022
The investigators from The Accelerated Medicines Partnership® Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP® RA/SLE) Program, in...
Lupus Research Alliance Launches Two Major Initiatives to Increase Participation of Underrepresented Minorities in Lupus Clinical Trials and Research
NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and clinical affiliate Lupus Therapeutics (LT) announced two major initiatives improving representation...
Shingles Vaccine Recommended for Immunocompromised People
January, 2022
As of January, 2022, the U.S. Centers for Disease Control and Prevention (CDC) recommends the use of the...